Work

Pcn204 Cost-estimate of Adding Neoadjuvant Pertuzumab for the Treatment of Her2+ Breast Cancer in an Institution in Portugal

Year: 2019

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2019.09.400

Authors: A. Borges, F. Pereira, P. Redondo, L. Antunes, C. Vieira, P. Antunes, M.J. Bento, S. Sousa, J. Machado Lopes, F.R. Gonçalves, J. Abreu de Sousa, D. Pereira, M. Borges

Institutions: IPO Porto, Universidade do Porto

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2996665693

Cites:

Cited by: 1

Related to: 10